How to reach us

Web disclaimer

The materials and other information provided by this Web site are for educational, communication and information purposes only and are not indended to replace or constitute the giving of medical advice or treatments. AAIQ intends that the information contained in this site to be accurate. However, errors sometimes occur. Therefore, AAIQ disclaims any warranty of any kind, whether express or implied, as to any matter whatsoever relating to this service. In no event shall AAIQ be liable for any indirect, special, incidental or consequential damages arising out of use of or reliance on any content or materials contained herein.

AAIQ does not assume and it hereby disclaims any and all liability to any person or entity for any claims, damages, liability or loss (including, without limitation, any liability for injury or other damage resulting from any use of or any reliance on this service or from the posting of any content or material by any third party). No use of, reliance on, any materials included in this site shall be deemed to give rise to a physician-patient relationship. No material included in this site shall be deemed to present the only or necessarily the best method or procedure with respect to a matter discussed on this service; rather, any such material shall be acknowledged as only the approach or opinion of the discussant.

The users assume all risks of using the materials included in this site.

Oral immunotherapy for the treatment of food allergies

Résumé

Oral immunotherapy (OIT) is a form of immunotherapy designed to treat food allergies. Contrary to subcutaneous immunotherapy (injections) or sublingual (oral administration of a liquid suspension of tablet), OIT consists of the direct ingestion of a food, in precisely measured amounts following a set calendar. This therapy starts at very small doses, below the threshold of reaction of the patient, and slowly increases until a normal portion of the food is ingested. Once at this maintenance dose, the patient must continue to ingest the food on a regular basis in order to maintain protection.

The 3 potential benefits of oral immunotherapy are:

To protect from reactions on an accidental basis

To reintegrate the food in the normal diet

To definitively resolve the allergy (sustained tolerance)

The success rates for the 2 former objectives are approximately 80% in certain studies and can exceed 90% in private clinics, possibly because of the greater flexibility of protocols. Sustained tolerance (the 3rd objective), which is defined by persistent tolerance to the food in question after a prolonged discontinuation of daily doses, may be possible after several years of treatment in certain patients.

In a recent survey in the United States, 13% of allergists were reported to practice oral immunotherapy. The University Hospital Centre of Sainte-Justine (CHU Sainte-Justine) is now happy to offer a new service treating food allergies with oral immunotherapy outside of a research context.

For additional information, please consult the document in detail (published 2016, French version).